➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Baxter
AstraZeneca
Harvard Business School
Boehringer Ingelheim

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Sirolimus - Generic Drug Details

« Back to Dashboard

Drug Prices for sirolimus

See drug prices for sirolimus

Recent Clinical Trials for sirolimus

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
ITB-Med LLCPhase 2
The Perron InstitutePhase 3
University of Kansas Medical CenterPhase 3

See all sirolimus clinical trials

Medical Subject Heading (MeSH) Categories for sirolimus
Paragraph IV (Patent) Challenges for SIROLIMUS
Tradename Dosage Ingredient NDA Submissiondate
RAPAMUNE TABLET;ORAL sirolimus 021110 2010-09-28
RAPAMUNE TABLET;ORAL sirolimus 021110 2010-08-25
RAPAMUNE TABLET;ORAL sirolimus 021110 2009-12-17

US Patents and Regulatory Information for sirolimus

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pf Prism Cv RAPAMUNE sirolimus TABLET;ORAL 021110-001 Aug 25, 2000 AB RX Yes No   Get Started Free   Get Started Free   Get Started Free
Zydus Pharms SIROLIMUS sirolimus TABLET;ORAL 201676-003 Jan 8, 2014 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Dr Reddys Labs Ltd SIROLIMUS sirolimus TABLET;ORAL 201578-002 Oct 27, 2014 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Glenmark Pharms Ltd SIROLIMUS sirolimus TABLET;ORAL 208691-001 Oct 16, 2020 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Alkem Labs Ltd SIROLIMUS sirolimus TABLET;ORAL 214753-002 Mar 12, 2021 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Glenmark Pharms Ltd SIROLIMUS sirolimus TABLET;ORAL 208691-003 Oct 16, 2020 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Dr Reddys Labs Ltd SIROLIMUS sirolimus TABLET;ORAL 201578-001 Oct 27, 2014 AB RX No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for sirolimus

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pf Prism Cv RAPAMUNE sirolimus TABLET;ORAL 021110-004 Jan 25, 2010   Get Started Free   Get Started Free
Pf Prism Cv RAPAMUNE sirolimus TABLET;ORAL 021110-002 Aug 22, 2002   Get Started Free   Get Started Free
Pf Prism Cv RAPAMUNE sirolimus TABLET;ORAL 021110-004 Jan 25, 2010   Get Started Free   Get Started Free
Pf Prism Cv RAPAMUNE sirolimus SOLUTION;ORAL 021083-001 Sep 15, 1999   Get Started Free   Get Started Free
Pf Prism Cv RAPAMUNE sirolimus SOLUTION;ORAL 021083-001 Sep 15, 1999   Get Started Free   Get Started Free
Pf Prism Cv RAPAMUNE sirolimus TABLET;ORAL 021110-004 Jan 25, 2010   Get Started Free   Get Started Free
Pf Prism Cv RAPAMUNE sirolimus TABLET;ORAL 021110-003 Feb 23, 2004   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Merck
Express Scripts
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.